Peter E. Westerweel
Impact in
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
Papers in
- Hematology 55
- Chronic Myeloid Leukemia Treatments 41
- Acute Myeloid Leukemia Research 13
- Genetics 34
- Chronic Lymphocytic Leukemia Research 30
- Co-authors
- Marianne Christina Verhaar (20 shared papers)Imo E. Hoefer (4 shared papers)Jan J. Cornelissen (15 shared papers)Mark‐David Levin (19 shared papers)Hein A. Koomans (2 shared papers)Jeroen J. W. M. Janssen (18 shared papers)Jan de Boer (1 shared paper)Clemens van Blitterswijk (1 shared paper)
- Journals
- Leukemia (8 papers)Blood (6 papers)European Journal Of Haematology (5 papers)Haematologica (5 papers)HemaSphere (5 papers)
- Partner nations
- NetherlandsGermanyUnited States
In The Last Decade
Peter E. Westerweel
111 papers receiving 3.2k citations
Peter E. Westerweel's Hit Papers
Peers
Comparison fields: 5 of 106
- Hematology 1.1k
- Internal Medicine 255
- Genetics 703
- Rheumatology 367
- Immunology 390
Countries citing papers authored by Peter E. Westerweel
This map shows the geographic impact of Peter E. Westerweel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Westerweel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Westerweel more than expected).
Fields of papers citing papers by Peter E. Westerweel
This network shows the impact of papers produced by Peter E. Westerweel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Westerweel. The network helps show where Peter E. Westerweel may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter E. Westerweel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 Hit paper breakdown → | 2021 | 501 |
| 2 | Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial Hit paper breakdown → | 2018 | 481 |
| 3 | 2017 | 178 | |
| 4 | 2019 | 115 | |
| 5 | 2009 | 104 | |
| 6 | 2007 | 101 | |
| 7 | 2007 | 93 | |
| 8 | 2010 | 74 | |
| 9 | 2007 | 73 | |
| 10 | 2022 | 70 | |
| 11 | Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism Hit paper breakdown → | 2025 | 63 |
| 12 | 2013 | 63 | |
| 13 | 2008 | 61 | |
| 14 | 2013 | 60 | |
| 15 | 2007 | 54 | |
| 16 | 2021 | 51 | |
| 17 | 2016 | 50 | |
| 18 | 2019 | 49 | |
| 19 | 2017 | 48 | |
| 20 | 2009 | 48 |
About Peter E. Westerweel
Peter E. Westerweel is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Internal Medicine, having authored 116 papers that have together received 3.3k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (41 papers), Chronic Lymphocytic Leukemia Research (30 papers), Lymphoma Diagnosis and Treatment (16 papers), Acute Myeloid Leukemia Research (13 papers), Angiogenesis and VEGF in Cancer (12 papers), Acute Lymphoblastic Leukemia research (9 papers), Immunodeficiency and Autoimmune Disorders (7 papers) and Eosinophilic Disorders and Syndromes (7 papers). The work is most often cited by research in Hematology (1.1k citations), Internal Medicine (255 citations), Genetics (703 citations), Rheumatology (367 citations) and Immunology (390 citations). Peter E. Westerweel has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Marianne Christina Verhaar, Imo E. Hoefer, Jan J. Cornelissen, Mark‐David Levin, Hein A. Koomans, Jeroen J. W. M. Janssen, Jan de Boer, Clemens van Blitterswijk, Jeroen Rouwkema and Ronald H. W. M. Derksen. Their work appears in journals such as Leukemia, Blood, European Journal Of Haematology, Haematologica and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.